- Report
- July 2024
- 288 Pages
Global
From €5389EUR$5,885USD£4,350GBP
- Report
- March 2025
- 175 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- May 2023
- 169 Pages
Global
From €2227EUR$2,350USD£1,861GBP
- Report
- January 2024
- 200 Pages
Global
From €3933EUR$4,150USD£3,286GBP
- Report
- April 2023
- 110 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- October 2023
- 78 Pages
United States
From €3317EUR$3,500USD£2,771GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €474EUR$500USD£396GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- November 2023
- 35 Pages
Global
From €3497EUR$3,690USD£2,922GBP
Truvada is a prescription medication used in combination with other antiretroviral drugs to treat HIV/AIDS. It is a combination of two drugs, tenofovir disoproxil fumarate and emtricitabine, which work together to reduce the amount of HIV in the body. Truvada is also used as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection in people who are at high risk of contracting the virus. PrEP is a daily pill that is taken to prevent HIV infection before exposure to the virus.
Truvada is manufactured by Gilead Sciences, Inc., and is available in the United States, Canada, and Europe. It is also available in generic form in some countries. Other companies that produce generic versions of Truvada include Mylan, Teva Pharmaceuticals, and Cipla. Show Less Read more
